1 results match your criteria: "I. I. Metchnikov Research Institute for Vaccines and Serum[Affiliation]"

Article Synopsis
  • Tγδ and B1 lymphocytes quickly respond to mucosal pathogens by producing antibodies, crucial for immediate immune protection without needing extra signals.
  • The study examined how different methods (subcutaneous, intranasal, and oral) to deliver the immunomodulator Immunovac-VP-4 affected these lymphocytes, revealing increases in Tγδ and B1 cell levels across various lymphoid tissues.
  • Mucosal application of Immunovac-VP-4 not only activated immune responses in local tissues but also enhanced migration of immune cells to distant organs, contributing to both local and systemic immunity.
View Article and Find Full Text PDF